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Abstract 
A semi-quantitative screening method was used to compare the killing efficacy of Ag 
zeolites against bacteria and yeast as a function of the zeolite type, crystal size and 
concentration. The method, which substantially reduced labor, consumables and waste 
and provided an excellent preliminary screen, was further validated by quantitative plate 
count experiments. Two pairs of zeolite X and zeolite beta with different sizes (ca. 200 
nm and 2 m for zeolite X and ca. 250 and 500 nm for zeolite beta) were tested against 
Escherichia coli (E. coli) and Candida albicans (C. albicans) at concentrations in the 
range 0.05 – 0.5 mg ml-1. Reduction of the zeolite crystal size resulted in a decrease in 
the killing efficacy against both microorganisms. The semi-quantitative tests allowed 
convenient optimization of the zeolite concentrations to achieve targeted killing times. 
Zeolite beta samples showed higher activity compared to zeolite X despite their lower 
Ag content, which was attributed to the higher concentration of silver released from 
zeolite beta samples. Cytotoxicity measurements using peripheral blood mononuclear 
cells (PBMCs) indicated that Ag zeolite X was more toxic than Ag zeolite beta. 
However, the trends for the dependence of cytotoxicity on zeolite crystal size at 
different zeolite concentrations were different for the two zeolites and no general 
conclusions about zeolite cytotoxicity could be drawn from these experiments. This 
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result indicates a complex relationship, requiring the necessity for individual 
cytotoxicity measurements for all antimicrobial applications based on the use of 
zeolites. 
Keywords: Silver zeolites; antimicrobial; killing efficacy; crystal size; cytotoxicity 
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1. Introduction 
Antimicrobial resistance is a global threat resulting in delayed recovery of 
patients and increased risk of spreading of infectious diseases, increased healthcare 
expenditures and increased mortality rates. Considering the lack of new antibiotics, 
therapeutic prevention of diseases is one of the main strategies considered to fight drug 
resistance. Silver-based materials have emerged as one of the most promising 
alternatives to combat multi-drug resistant microorganisms [1]. The range of materials, 
mechanism of antibacterial action, issues and challenges in the use of silver as 
antibacterial agent have been discussed in several excellent reviews [2-5]. Amongst 
silver carriers used, zeolites have many attractive properties, such as: (i) rigid 
frameworks with high chemical, mechanical and thermal stability and (ii) high surface 
areas and micropore systems allowing slow silver release. Their ion-exchange 
properties enable the application of simple synthetic protocols for introduction of silver 
ions with the possibility for subsequent silver reduction to form silver nanoparticles. 
Currently, there are 231 zeolite structures approved by the Zeolite Structure 
Commission [6]. Only a handful of these structures have been tested as silver supports 
for antimicrobial applications, providing a scope for extensive future research. Such 
research will also inform the design of innovative multifunctional materials based on 
Ag zeolites, examples of which can already be found in the literature [7]. 
There are a number of factors affecting the antimicrobial activity of silver 
zeolites. Direct comparison of different studies is often difficult because of the different 
testing methods used such as the agar well diffusion and fluorescence assays or the 
culture growth suppression spectrophotometric method [8-10]. The antibacterial activity 
of Ag zeolites increased with increasing the Ag content in parent ETS-10, A and EMT 
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zeolites [11-13]. In each of these works, six Ag zeolite samples were tested, three after 
Ag ion-exchange at different levels, and three after subsequent silver reduction. The 
samples prepared after Ag reduction showed higher activity [11,13]. Additionally, we 
have demonstrated that the design of the microbiology tests, for instance the selection of 
a growth medium, can be significant for the results obtained [13]. Further, the 
antimicrobial properties of Ag zeolites were dependent on the zeolite structure (pore 
sizes, pore channel systems) rather than the amount of silver exchanged in the zeolite 
[14]. ZSM-5 containing only 0.2 wt.% Ag has been reported to be active against 
Staphylococcus aureus [15]. Even variations in the Si/Al ratio within the same zeolite-
type structure, e.g., zeolite X and zeolite Y, FAU-type structure, were found to 
influence the minimum inhibitory concentration against bacteria [16]. The antimicrobial 
activity of Ag zeolites could be further improved by introducing a second metal such as 
Zn [17]. 
For biomedical applications, the determination of the cytotoxicity of Ag zeolites 
is of paramount importance, but such studies are rarely carried out. Greulich et al. have 
reported that the toxic effect of silver towards bacterial and mammalian cells is similar 
[18]. Zeolites themselves have shown cytotoxicity depending on zeolite type, dose and 
cells used [19,20]. Ultrasmall, 8-18 nm EMT and LTL, zeolites have demonstrated 
absence of cytotoxicity at concentrations between 100 and 400 g ml-1 [21]. Two recent 
reviews discuss aspects of nanozeolite cytotoxicity in more detail [22,23]. In addition, 
an acute toxicity has been reported for silver ions in nanosized EMT-type zeolites, 
however the tests were performed on animal cell lines and human tumor cells [24].  
Nanozeolites comprise one of the major developments in the zeolite area since 
their first synthesis in the early 1990s [25]. There are examples of their superior 
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performance compared to conventional micron-sized zeolites in traditional applications 
such as catalysis. In addition, they have shown potential for many emerging 
applications [23]. The effect of zeolite crystal size on the antimicrobial properties of Ag 
zeolites has not been systematically studied so far. Considering the particulars of 
synthesis approaches used to prepare such zeolites, for example high-speed 
centrifugation during their post-synthesis purification and metal ion-exchange, such a 
study will be highly beneficial to assess their profitability as antimicrobials. Another 
objective of the present paper was to develop a reliable microbiology method allowing 
screening of a large number of zeolite samples for quick assessment of their microbial 
killing efficacy to inform the selection of zeolite samples, e.g., zeolite type and crystal 
size, and to determine optimum zeolite concentrations for a particular microbiology 
application. Escherichia coli (E. coli) was used as a model for Gram-negative bacteria 
[26]. The yeast Candida albicans (C. albicans), a recognized human pathogen [27], that 
has shown to be less sensitive to Ag zeolites compared to bacteria [28], was also used. 
In addition, the cytotoxicity of the Ag-exchanged zeolite X and zeolite beta samples was 
determined using human peripheral blood mononuclear cells isolated from healthy 
volunteers’ human blood. 
2. Materials and methods 
2.1 Zeolite synthesis 
Zeolite X (X1 and X2) and zeolite beta (B1 and B2) samples were synthesized 
by hydrothermal treatment (Table 1). Sample X1 was prepared from a gel with the 
molar composition 5.5Na2O : 1.0Al2O3 : 4.0SiO2 : 190H2O using NaAlO2 (Fischer), 
NaOH (Alfa Aesar), fumed silica (Aerosil 200, Degussa) and distilled water [29]. The 
mixture was stirred at room temperature for 24 h, transferred to a polypropylene reactor 
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and hydrothermally treated at 60 °C for 4 days. After the synthesis, the sample was 
purified by three-times centrifugation and redispersion in distilled water and dried at 60 
°C overnight. Sample X2 was prepared from a gel with the molar composition 8NaOH : 
0.2Al2O3 : 1.0SiO2 : 200H2O as described previously [30]. The precursor gel was 
transferred to a Teflon-lined autoclave and treated at 110 °C for 3 h. 
Zeolite beta samples were synthesized form a clear precursor solution with the 
molar composition 0.3Na2O : 9TEAOH : 0.5Al2O3 : 25SiO2 : 489H2O using aluminum 
isopropoxide (Alfa Aesar), silica sol (Bindzil 30/220, EKA Chemicals), 
tetraethylammonium hydroxide (20 wt.% aqueous solution, Alfa Aesar) and distilled 
water [31]. Sample B1 was prepared by hydrothermal treatment at 150 °C for 48 h, 
whereas for sample B2 the crystallization was performed at 170 °C for 38 h. Both 
samples were purified by three-times centrifugation and redispersion in distilled water 
and dried at 60 °C overnight. The organic template was removed by calcination at 550 
°C for 5 h after heating to that temperature at a rate of 10 °C min-1. 
The as-made zeolite samples were ion-exchanged with silver as described 
previously [28]. Each sample was mixed with a 0.05 M AgNO3 solution (AgNO3, 
99+%, Alfa Aesar) at a solution to sample weight ratio of 20 and stirred for 72 h in the 
dark. The samples were then centrifuged three times (6000 rpm, 10 min) and 
redispersed in distilled water, and finally dried at 60 °C overnight. 
2.2. Characterization methods 
Zeolite crystal sizes were determined with a Carl Zeiss Ltd 40VP Supra 
Scanning Electron Microscope (SEM). The particle sizes of samples X1, B1 and B2 
were also verified by dynamic light scattering (DLS) using a Zetasizer Nano ZS 
instrument with a 173° backscattering angle geometry. Semi-quantitative chemical 
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analysis was performed on uncoated sample pellets by energy-dispersive X-ray 
spectroscopy (EDS) using an Apollo 40 SDD detector (EDAX Inc.). The average of five 
measurements was used in the determinations. X-ray diffraction (XRD) patterns were 
collected with a PANalytical X’Pert X-ray diffractometer (XRD) employing Cu Kα 
radiation (40 kV and 30 mA) and a PIXcell detector. Nitrogen adsorption isotherms of 
the zeolite samples prior to silver ion-exchange were recorded on a Micromeritics 
ASAP 2020 surface area analyzer at -196 °C. Samples were degassed at 300 °C 
overnight prior to analysis. BET areas were calculated using the BET equation, whereas 
external surface areas (SEXT) and micropore volumes (V) were determined by the t-plot 
method. BJH pore-size distributions were determined from the desorption branch of the 
isotherms. 
2.3. Antimicrobial tests 
A single colony of E. coli (ATCC 8739) from a freshly cultured nutrient agar 
(Oxoid, UK) plate was removed using a sterile loop and inoculated in 100 ml of sterile 
nutrient broth (Oxoid, UK). Broth was incubated for 18 h at 37 °C in a rotary shaker 
incubator set at 150 rpm. The liquid culture was centrifuged at 3000 rpm for 10 min so 
that cells formed a pellet, which was re-suspended in distilled water. An optical density 
of 1.0 at 540 nm wavelength was obtained (Jenway 6305 Spectrophotometer, UK), 
corresponding to approximately 108 colony-forming units (CFU) per ml. The same 
procedure was applied for C. albicans (NCYC 1363) but the overnight growth was 
performed in Sabouraud dextrose liquid medium and the approximate starting 
concentration of the yeast suspension was 105 colony forming units (CFU) per ml. 25 μl 
of the bacterial or yeast suspensions were added to 20 ml of 0.5, 0.1 and 0.05 mg ml-1 
Ag zeolite suspensions and vortexed immediately for 30 s. Corresponding Ag-free 
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samples were used for control experiments. The samples were incubated at 37 °C in a 
rotary shaker incubator set at 150 rpm and a sample was taken immediately after mixing 
(zero min) and then every min for up to 7 min with vortexing immediately before 
sampling. A single drop (0.02 ml) of sample was added to one segment of thioglycollate 
agar (ThGA) plate divided into 8 segments. The ThGA plate was prepared by mixing 
thioglycollate broth with 1.2 wt.% technical agar (Oxoid, UK). The role of this agar is 
to neutralize the bactericidal effect of silver at the selected sampling times [32]. All tests 
were carried out in duplicate. The plates were incubated overnight at 37 °C and then 
visually evaluated to compare the silver zeolites’ killing efficacy as a function of the 
zeolite crystal size, zeolite type and zeolite concentration indicated by +/- growth.  
The release of silver from the zeolite samples was measured in the mother liquor 
immediately after the 7-min semi-quantitative tests. The suspensions were centrifuged 
at 3000 rpm for 10 min, the pellet formed was discarded and the supernatant was 
analyzed on a Thermo Scientific iCAP6300 Duo inductively coupled plasma optical 
emission spectrometer (ICP-OES) using the Ag 328.1 nm analytical wavelength. 
Quantitative plate count experiments using E. coli were performed to verify the 
conclusions drawn by the semi-quantitative microbiology tests. The E. coli suspension 
(25 l, 108 CFU ml-1) was added to 5 ml of 0.5 mg ml-1 suspensions of the Ag zeolite 
samples. Ag-free zeolite X and zeolite beta samples were used for negative control 
experiments. The samples were incubated at 37 °C in a rotary shaker incubator set at 
150 rpm. A sample (100 µl) was taken every min between 0 and 7 min with vortexing 
prior to sampling, inoculated in 900 µl phosphate buffer saline (PBS) and then serially 
diluted ten-fold in the range 10-2 to 10-4. Each diluted sample (100 l) was inoculated 
onto duplicate plates of ThGA, spread, dried and incubated overnight at 37 °C. The 
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number of colonies was counted for the dilution giving the highest countable number of 
cells and the average CFU per ml of original suspension was then calculated. It is 
important to mention that there was a delay of approximately 10 min between sampling 
and plating onto the ThGA plates due to dilution. This delay time was consistent across 
all samples studied. 
2.4. Cytotoxicity tests 
Peripheral blood mononuclear cells (PBMCs) were isolated from donated blood 
of healthy individuals (n=3, one female and two males, age between 20-25 years old) as 
previously described [33]. An in house ethical approval protocol (Manchester 
Metropolitan University) was followed. The blood (20 ml) was carefully layered on the 
same volume of Ficoll-Paque PLUS (GE Healthcare Life Sciences, Buckinghamshire, 
UK). After 40 min centrifugation at 400 × g at 18–20 °C, the peripheral blood 
mononuclear cells layer was carefully removed and washed twice with RPMI-1640 
medium. Isolated PBMCs (3x105 per well) were cultured in flat-bottomed 24-well 
plates [34]. PBMCs were grown in RPMI-1640 medium containing Ag zeolite (X1, X2, 
B1 and B2) samples of different concentrations (1, 0.5, 0.1, 0.05 and 0.001 mg ml-1), 
10% (v⁄v) human AB serum and 1% penicillin/streptomycin at 37 °C in 5% CO2. Three 
experiments (blood from three volunteers) were performed for each zeolite 
concentration with 8 readings obtained for X1 and X2 samples (one duplicate and two 
triplicates) and 7 readings obtained for B1 and B2 samples as well as the untreated cells 
(two duplicates and one triplicate) The amount of Ag zeolite needed to obtain the above 
concentrations was firstly added to PBS and vortexed. After two weeks, the samples 
were centrifuged and the supernatant was used in the cytotoxicity tests. All cultures 
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were supplemented with 50 U ml-1 human recombinant interleukin-2 (IL-2) (R&D 
Systems Abingdon, UK). 
Flow cytometry, which is widely used to determine apoptotic population using 
pre-G1, was employed to measure the cytotoxic effect of silver zeolites on PBMCs 
apoptosis, following 48 h in culture [35]. The PBMCs were harvested and washed in 
PBS prior to fixing at -20 °C in 75% ethanol. After a minimum of 24 h, the PBMCs 
were washed twice in PBS and re-suspended with gentle vortexing in propidium iodide 
labelling buffer (50 g ml-1 propidium iodide, 0.1% sodium citrate, 20 g ml-1 
ribonuclease A, 0.3% Nonidet P-40, pH 8.3) at approximately 1x106 cells ml-1. The 
PBMCs were analyzed using a Becton Dickinson FACSCalibur flow cytometer. Data 
were analyzed using Cell Quest software (Becton Dickinson, Oxford, UK). Statistical 
significance of the results for zeolite-treated cells and untreated cells was determined 
with a one-way ANOVA followed by Tukey-Kramerith multiple post hoc analysis. All 
results are presented as mean ± standard deviation of the mean (N= 7 or 8 as discussed 
above). Results were considered as statistically significant when p< 0.05. 
3. Results and discussion 
3.1. Zeolite characteristics 
SEM was used to determine the particle size distributions of the samples used in 
this study (Fig. 1) and data is presented in Table 1. Sample X1 contained nanosized 
crystals with sizes of about 200 nm, whereas the crystal sizes of sample X2 were one 
order of magnitude larger (Fig. 1 a,b). B2 crystals were about two times larger 
compared to B1 crystals. The crystal sizes of samples X1, B1 and B2 were also 
measured by DLS (Fig. S1, Supporting Information) and the average Z sizes determined 
were 258, 254 and 576 nm, respectively. 
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The samples were further analyzed by XRD (Fig. S2). The XRD analysis 
confirmed the presence of zeolite X and zeolite beta, correspondingly, as single phases. 
The XRD peak intensities of the X1 sample were considerably lower compared to these 
of X2 and the peaks were broader. Both effects can be attributed to the reduction of 
crystal sizes in X1 to nano-dimensions [36]. The Ag ion-exchange resulted in changes 
in the relative intensities of the (220), (311) and (331) faujasite peaks in the XRD 
patterns of the Ag-exchanged zeolite X compared to the NaX sample in accordance with 
our previous results (not shown) [28]. No changes were observed in the XRD patterns 
of the zeolite beta samples after the Ag ion-exchange and both zeolite beta samples 
were highly crystalline (Fig. S2). 
Differences in the textural characteristics of the different samples were observed 
according to nitrogen adsorption data (Fig. S3). All zeolites showed type I isotherms 
with a hysteresis loop at high relative pressures in the isotherms of samples X1 and B1 
due to interparticle textural porosity associated with small particle sizes [23]. The 
external surface areas increased with a decrease in the particle size accordingly (Table 
1). Similar micropore volumes were determined for samples X1 and X2, which were 
typical of a highly crystalline FAU-type zeolite [23]. The pore-size distributions further 
outlined the differences in the secondary (non-zeolite) porosity of the samples (Fig, S3, 
inserts). Sharp mesoporous peaks centered around 45-50 nm were present in the pore-
size distribution plots of samples X1 and B1. 
3.2. Antimicrobial tests 
The zeolite samples were compared directly in terms of their antimicrobial 
efficacy by semi-quantitative tests. Three different zeolite concentrations were selected 
for the tests based on our previous results [37]. The Ag zeolite samples at different 
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concentrations were tested against E. coli and C. albicans. The Ag-free samples used as 
controls did not show any antimicrobial activity. The results for zeolite concentrations 
of 0.5 mg ml-1 and both microorganisms are shown in Figs. 2 and 3. The number of 
viable E. coli colonies visually decreased with time for both zeolite X samples (Fig. 2), 
although this was less apparent in the presence of the nanosized X1 sample after 7 min. 
No colonies could be seen at the 7 min sampling time for the micron-sized sample X2. 
The zeolite beta samples were more efficient compared to zeolite X and killed E. coli 
within 2 min (Fig. 2). An increase in the crystal size increased the killing efficacy for 
this zeolite as well. The experiments performed with two additional zeolite 
concentrations, 0.05 and 0.1 mg ml-1, showed similar trends regarding the influence of 
the crystal size on the killing efficacy (Supporting Information, Fig. S4 and Fig. S5). 
Zeolite X samples were not active at 0.05 mg ml-1 concentration within the 7-min test 
period (Fig. S4). At 0.1 mg ml-1 concentration, sample X2 was clearly more active than 
sample X1, although growth was still detected after 7 min using this sample (Fig. S4). 
In the case of zeolite beta, no growth was observed after 7 and 6 min for B1 and B2, 
respectively at 0.05 mg ml-1 concentration, and after 6 and 5 min, respectively at 0.1 mg 
ml-1 concentration (Fig. S5). 
The 0.5 mg ml-1 zeolite concentration was also tested against C. albicans (Fig. 
3). The results also suggest that larger-sized zeolites are more efficient against yeast. 
Zeolite beta was again more active compared to zeolite X. It is worth noting that owing 
to the much larger C. albicans cells and their lower initial concentration of test 
suspension compared to E. coli, the results for the two microorganisms cannot be 
compared directly. 
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The silver release data is provided in Table 2. The amount of released silver was 
higher for all zeolite beta samples despite their lower Ag loading, which could explain 
their higher activity. Daniel et al. have shown that there are distinct differences in the 
estimated number and strength of adsorption sites for Xe in silver-modified zeolites X 
and beta, suggesting that differences could be expected for their Ag release profiles 
[38]. Extra- framework aluminum has also been speculated to hinder the silver release 
[14]. Additionally, smaller crystals may be aggregated to a larger extent in the testing 
medium to obstruct the release of silver and lower concentrations of Ag were measured 
for samples X1 and B1 compared to X2 and B2, respectively. 
The semi-quantitative microbiology tests indicated that the zeolite killing 
efficacy was higher for zeolite beta compared to zeolite X and it increases with an 
increase in the zeolite crystal size. These conclusions were further verified by 
performing quantitative plate count experiments using E. coli. The results from these 
experiments confirm that zeolite beta is more active compared to zeolite X and also that 
the larger-sized crystals are more efficient (Fig. 4). The reduction in labor, consumables 
and waste using the semi-quantitative tests prior to quantitative measurements is 
remarkable. For example, the inoculation of E. coli on ThGA plates using the five 
zeolite samples (control, X1, X2, B1 and B2) took 35 min and required 10 plates in the 
case of the semi-quantitative procedure, and 125 min and 320 plates, respectively when, 
the quantitative measurements were employed. Considering the varying results for the 
dependence of the killing efficacy on the zeolite concentration, crystal size and zeolite 
type, the use of the semi-quantitative procedure offers unique advantages in 
microbiology experiments employing zeolites and related materials. Killing times are 
also organism-dependent and many tests are usually required to select appropriate 
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concentrations and sampling times for test materials. The screening semi-quantitative 
method used in this work increased the efficiency of microbiology tests substantially. 
3.3. Cytotoxicity tests 
For cytotoxicity tests, PBMCs were cultured for 2 days under the conditions 
described in Experimental. At the end of cell treatments, PBMCs were subjected to flow 
cytometry analysis for Pre-G1 (apoptosis marker) and results are shown in Fig. 5. 
According to the results, all zeolites were non-toxic at concentrations of 0.05 mg ml-1 
and below. Moreover, zeolites X2, B1 and B2 samples were non-toxic even at higher 
concentrations, 0.1 mg ml-1 for X2 and B2 and 0.5 mg ml-1 for B1. The zeolite beta 
samples were highly active against both microorganisms at these concentrations (Figs. 
2, 3 and Fig. S5, Supporting Information). The higher toxicity of zeolite X samples 
could not be explained by the amount of Ag released, which was lower compared to that 
for beta (Table 2). Thus, a possible explanation might be the higher aluminum content 
and associated cytotoxicity of the zeolite itself [20]. The cytotoxicity tests indicate that 
the relationship between the Ag zeolites and cytotoxicity is complex and depends on 
many factors such as zeolite type, zeolite concentration and zeolite characteristics. 
4. Conclusion 
The effect of zeolite structure, crystal size and concentration on the 
antimicrobial efficacy of two Ag zeolites, zeolite X and zeolite beta, was studied by a 
semi-quantitative method. Zeolite beta was found to be more efficient compared to 
zeolite X and no viable cells of E. coli and C. albicans were observed within 2 min of 
incubation with both microorganisms using zeolite concentrations of 0.5 mg ml-1. 
Reduction of crystal size resulted in an increase in E. coli killing time as a result of 
reduced Ag content released to the medium by the smaller crystals. The results obtained 
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by the semi-quantitative antimicrobial tests used were verified by the application of a 
quantitative count plate experiments. The semi-quantitative procedure reported here 
substantially reduces labor, consumables and waste, and can be adopted for testing other 
materials. Cytotoxicity measurements showed that zeolite X was more toxic compared 
to zeolite beta, and the effect was more pronounced for the nanosized zeolite X. The 
results reported here will be of interest when selecting silver zeolites for biomedical 
applications, particularly when fast antimicrobial response is required, to optimize the 
zeolite carrier in terms of structural and textural characteristics, zeolite concentration 
and antimicrobial metal concentration and form. 
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Figure captions 
Figure 1. SEM images of: (a) X1, (b) X2, (c) B1, and (d) B2. 
 
Figure 2. Spot inoculation of E. coli onto ThGA plates (in duplicate) following 1 min 
interval exposure to the different zeolite samples. Each drawn segment on the plates 
above corresponds to one min sampling time; the first sample (top) is taken directly 
after mixing (0 min) with clockwise inoculation over time. 
 
Figure 3. Spot inoculation of C. albicans onto ThGA plates (in duplicate) following 1 
min interval exposure to the different zeolite samples. Each drawn segment on the plates 
above corresponds to one min sampling time; the first sample (top) is taken directly 
after mixing (0 min) with clockwise inoculation over time. 
 
Figure 4. Antibacterial effect of: (a) zeolite X and (b) zeolite beta on E. coli over 7-min 
exposure. The asterisks * in (a) indicates fewer than 20 colonies at 10-1 dilution. 
 
Figure 5. Cytotoxic effect of silver zeolite samples of different concentrations on freshly 
isolated cultured PBMCs. Asterisks (*) indicate significant differences in comparison 
with the control (* p<0.05, ** p<0.01, *** p<0.001). 
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Table 1. Physicochemical characteristics of the Ag zeolite samples used. 
Sample Zeolite 
type 
Crystal size 
(SEM) 
Si/Al 
ratio 
Ag 
(wt.%) 
BET area 
(m2 g-1) 
V (cm3 g-
1) 
SEXT 
(m2 g-
1) 
X1 X 180-230 nm 1.2 10.8 691 0.30 62 
X2 X 1.2-2.2 m 1.2 10.7 687 0.31 42 
B1 beta 200-300 nm 13.4 2.4 639 0.22 186 
B2 beta 400-500 nm 17.2 2.3 530 0.20 108 
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Table 2. Ag released (ppm) after the 7-minute tests using E. coli as a function of 
the zeolite type and zeolite concentration. 
 0.05 mg ml-1 0.1 mg ml-1 0.5 mg ml-1 
X1 0.02±0.01 0.04±0.01 0.05±0.00 
X2 0.11±0.01 0.14±0.01 0.15±0.01 
B1 1.01±0.10 1.00±0.04 1.71±0.08 
B2 1.52±0.24 1.70±0.07 2.19±0.11 
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Figure 5  
